Georgy Novikov

• Managed sales and product promotion for immunology (Simzia – Certolizumab Pegol) across St. Petersburg and NWFD regions.
• Built relationships with Key Opinion Leaders, healthcare committees, and regional distributors.
• Secured inclusion of company products in Clinical Statistical Groups (CSG) and hospital formularies, increasing market share regionally.
• Negotiated procurement agreements with healthcare ministries, expanding product availability in new territories (Murmansk, Kaliningrad, Pskov).
• Monitored tenders, analyzed competitor activities, and adjusted strategies accordingly.
• Organized professional events (round tables, conferences) to support business development.

Key Achievements:

• Established business operations in NWFD regions from the ground up.
• Doubled market share in St. Petersburg through strategic negotiations.
• Expanded sales to previously untapped regions, achieving significant procurement agreements.

• Launched and promoted oncology product Adcetris (Brentuximab Vedotin) in NWFD regions.
• Worked with KOLs, regional healthcare ministries, and distributors to include products in formularies and secure funding sources.
• Achieved funding approval for 24 Hodgkin's Lymphoma patients through St. Petersburg’s regional healthcare program.

• Managed market access for a portfolio across immunology (Remicade, Simponi), oncology (Temodal, Emend), and other specialties.
• Secured product inclusion in regional programs and formularies, increasing market share.
• Negotiated a major deal for Remicade worth 140M RUB through supplemental funding.
• Expanded access to Victrelis by successfully integrating it into Murmansk's regional healthcare program.